{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T18:42:44Z","timestamp":1791139364897,"version":"4.1.0"},"reference-count":156,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"Supplement 1","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":3499,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2006,2]]},"abstract":"<jats:sec>\n            <jats:title\/>\n            <jats:p>\n                                 <jats:bold>In 1950, Waldenstr\u00f6m was the first to describe a chronic form of hepatitis in young women. Subsequently, the disease was found to be associated with other autoimmune syndromes and was later termed \u201clupoid hepatitis\u201d because of the presence of antinuclear antibodies. In 1965, it became designated by Mackay et al. as \u201cautoimmune hepatitis\u201d at an international meeting, at which the general concept of autoimmunity was endorsed by the scientific community. In the early 1960s and 1970s, the value of immunosuppressive therapy with glucocorticoids and\/or azathioprine was well documented in several studies. The original association of autoimmune hepatitis (AIH) and HLA alleles, which has remarkably stood the test of time, was published in 1972. In the 1970s and 1980s, several autoantibodies were identified in patients withautoimmunehepatitis directed against proteins of the endoplasmatic reticulum expressed in liver and kidney and against soluble liver antigens. Subsequently, the molecular targets of these antibodies were identified and more precisely characterized. In the last two decades many additional pieces of the AIH puzzle have been collected leading to the identification of additional antibodies and genes associated with AIH and to the emergence of new therapeutic agents. Meanwhile, the immunoserological and genetic heterogeneity of AIH is well established and it has become obvious that clinical manifestations, disease behavior, and treatment outcome may vary by racial groups, geographical regions and genetic predisposition. Currently, the International Autoimmune hepatitis group is endorsing multi-center collaborative studies to more precisely define the features at disease presentation and to define prognostic indices and appropriate treatment algorithms. Given the importance of serological testing, the IAHG is also working on guidelines and procedures for more reliable and standardized testing of autoantibodies.<\/jats:bold>\n                              <\/jats:p>\n          <\/jats:sec>","DOI":"10.1002\/hep.21059","type":"journal-article","created":{"date-parts":[[2006,1,31]],"date-time":"2006-01-31T00:47:00Z","timestamp":1138668420000},"page":"S132-S144","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":140,"title":["Autoimmune Hepatitis, From Mechanisms to Therapy"],"prefix":"10.1097","volume":"43","author":[{"given":"Michael P.","family":"Manns","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arndt","family":"Vogel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-12-20241202","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1002\/hep.1840190629","article-title":"Classification of chronic hepatitis: diagnosis, grading and staging","volume":"19","author":"Desmet","year":"1994","journal-title":"Hepatology"},{"key":"R2-12-20241202","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/S0168-8278(99)80297-9","article-title":"International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis","volume":"31","author":"Alvarez","year":"1999","journal-title":"J Hepatol"},{"key":"R3-12-20241202","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/hep.20732","article-title":"Autoimmune hepatitis: effect of symptoms and cirrhosis on natural history and outcome","volume":"42","author":"Feld","year":"2005","journal-title":"Hepatology"},{"key":"R4-12-20241202","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1002\/hep.510250308","article-title":"Autoimmune hepatitis in childhood: a 20-year experience","volume":"25","author":"Gregorio","year":"1997","journal-title":"Hepatology"},{"key":"R5-12-20241202","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1111\/j.1478-3231.2004.0924.x","article-title":"Diagnostic and therapeutic implications of bile duct injury in autoimmune hepatitis","volume":"24","author":"Czaja","year":"2004","journal-title":"Liver Int"},{"key":"R6-12-20241202","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1055\/s-2002-35705","article-title":"Genetics in autoimmune hepatitis","volume":"22","author":"Donaldson","year":"2002","journal-title":"Semin Liver Dis"},{"key":"R7-12-20241202","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S0168-8278(00)80004-5","article-title":"Overlap of autoimmune hepatitis and primary sclerosing cholangitis: an evaluation of a modified scoring system","volume":"33","author":"Kaya","year":"2000","journal-title":"J Hepatol"},{"key":"R8-12-20241202","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1111\/j.1572-0241.2002.05703.x","article-title":"Overlap of autoimmune hepatitis and primary biliary cirrhosis: an evaluation of a modified scoring system","volume":"97","author":"Talwalkar","year":"2002","journal-title":"Am J Gastroenterol"},{"key":"R9-12-20241202","doi-asserted-by":"crossref","first-page":"7893","DOI":"10.1136\/gut.21.1.78","article-title":"Late results of the Royal Free Hospital prospective controlled trial of prednisolone therapy in hepatitis B surface antigen negative chronic active hepatitis","volume":"21","author":"Kirk","year":"1980","journal-title":"Gut"},{"key":"R10-12-20241202","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1093\/oxfordjournals.qjmed.a067264","article-title":"Controlled prospective trial of corticosteroid therapy in active chronic hepatitis","volume":"40","author":"Cook","year":"1971","journal-title":"Q J Med"},{"key":"R11-12-20241202","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/S0140-6736(73)92125-9","article-title":"Controlled trial of prednisone and azathioprine in active chronic hepatitis","volume":"I","author":"Murray-Lyon","year":"1973","journal-title":"Lancet"},{"key":"R12-12-20241202","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1136\/gut.4.4.378","article-title":"Active juvenile cirrhosis considered as part of a systemic disease associated and the effect of corticosteroid therapy","volume":"4","author":"Read","year":"1963","journal-title":"Gut"},{"key":"R13-12-20241202","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1053\/gast.1996.v110.pm8608895","article-title":"Prognosis of histological cirrhosis in type 1 autoimmune hepatitis","volume":"110","author":"Roberts","year":"1996","journal-title":"Gastroenterology"},{"key":"R14-12-20241202","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1097\/00004836-200207000-00016","article-title":"Prognosis of symptomatic versus asymptomatic autoimmune hepatitis: a study of 68 patients","volume":"35","author":"Kogan","year":"2002","journal-title":"J Clin Gastroenterol"},{"key":"R15-12-20241202","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.jhep.2004.01.009","article-title":"Decreased fibrosis during corticosteroid therapy of autoimmune hepatitis","volume":"40","author":"Czaja","year":"2004","journal-title":"J Hepatol"},{"key":"R16-12-20241202","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1111\/j.1572-0241.2004.30457.x","article-title":"Factors predicting relapse and poor outcome in type I autoimmune hepatitis: role of cirrhosis development, patterns of transaminases during remission and plasma cell activity in the liver biopsy","volume":"99","author":"Verma","year":"2004","journal-title":"Am J Gastroenterol"},{"key":"R17-12-20241202","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.jaut.2004.11.009","article-title":"Clinical features and biochemical data of Caucasian children at diagnosis of autoimmune hepatitis","volume":"24","author":"Oettinger","year":"2005","journal-title":"J Autoimmun"},{"key":"R18-12-20241202","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1002\/hep.1840070626","article-title":"Chronic active hepatitis associated with anti liver\/kidney microsome type 1: a second type of\u201cautoimmune\u201dhepatitis","volume":"7","author":"Homberg","year":"1987","journal-title":"Hepatology"},{"key":"R19-12-20241202","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1111\/j.1572-0241.2001.03782.x","article-title":"Autoimmune hepatitis in the elderly","volume":"96","author":"Schramm","year":"2001","journal-title":"Am J Gastroenterol"},{"key":"R20-12-20241202","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1111\/j.1365-2036.2005.02488.x","article-title":"Clinical features of type 1 autoimmune hepatitis in elderly Italian patients","volume":"21","author":"Granito","year":"2005","journal-title":"Aliment Pharmacol Ther"},{"key":"R21-12-20241202","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1111\/j.1365-2036.2005.02403.x","article-title":"Diagnosis and treatment of autoimmune hepatitis at age 65 and older","volume":"21","author":"Verslype","year":"2005","journal-title":"Aliment Pharmacol Ther"},{"key":"R22-12-20241202","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1093\/ageing\/26.6.441","article-title":"Autoimmune hepatitis in older patients","volume":"26","author":"Newton","year":"1997","journal-title":"Age Ageing"},{"key":"R23-12-20241202","doi-asserted-by":"crossref","first-page":"3390","DOI":"10.1111\/j.1572-0241.2001.05272.x","article-title":"Autoimmune hepatitis in African Americans: presenting features and response to therapy","volume":"96","author":"Lim","year":"2001","journal-title":"Am J Gastroenterol"},{"key":"R24-12-20241202","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1002\/hep.510300611","article-title":"Pediatric and adult forms of type I autoimmune hepatitis in Argentina: evidence for differential genetic predisposition","volume":"30","author":"Pando","year":"1999","journal-title":"Hepatology"},{"key":"R25-12-20241202","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1136\/gut.50.5.713","article-title":"Characteristics of autoimmune hepatitis in patients who are not of European Caucasoid ethnic origin","volume":"50","author":"Zolfino","year":"2002","journal-title":"Gut"},{"key":"R26-12-20241202","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.1111\/j.1572-0241.2002.06019.x","article-title":"Prevalence of autoimmune liver disease in Alaska Natives","volume":"97","author":"Hurlburt","year":"2002","journal-title":"Am J Gastroenterol"},{"key":"R27-12-20241202","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1136\/gut.38.4.610","article-title":"Natural history and prognostic factors in 305 Swedish patients with primary sclerosing cholangitis","volume":"38","author":"Broome","year":"1996","journal-title":"Gut"},{"key":"R28-12-20241202","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1023\/A:1005638500236","article-title":"Hepatocellular carcinoma in autoimmune hepatitis","volume":"45","author":"Park","year":"2000","journal-title":"Dig Dis Sci"},{"key":"R29-12-20241202","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1080\/0891693021000056721","article-title":"Organ and non-organ specific autoantibody titres and IgG levels as markers of disease activity: a longitudinal study in childhood autoimmune liver disease","volume":"35","author":"Gregorio","year":"2002","journal-title":"Autoimmunity"},{"key":"R30-12-20241202","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.jhep.2004.08.002","article-title":"Liver autoimmune serology: a consensus statement from the committee for autoimmune serology of the International Autoimmune Hepatitis Group","volume":"41","author":"Vergani","year":"2004","journal-title":"J Hepatol"},{"key":"R31-12-20241202","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1023\/B:DDAS.0000026306.36511.c8","article-title":"Frequency and significance of antibodies to Saccharomyces cerevisiae in autoimmune hepatitis","volume":"49","author":"Czaja","year":"2004","journal-title":"Dig Dis Sci"},{"key":"R32-12-20241202","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1023\/A:1024748714580","article-title":"Frequency and significance of antibodies to chromatin in autoimmune hepatitis","volume":"48","author":"Czaja","year":"2003","journal-title":"Dig Dis Sci"},{"key":"R33-12-20241202","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.jaut.2005.01.016","article-title":"Prevalence and clinical significance of anticardiolipin antibodies in patients with type 1 autoimmune hepatitis","volume":"24","author":"Liaskos","year":"2005","journal-title":"J Autoimmun"},{"key":"R34-12-20241202","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1055\/s-2002-35704","article-title":"Autoantibodies and autoantigens in autoimmune hepatitis","volume":"22","author":"Strassburg","year":"2002","journal-title":"Semin Liver Dis"},{"key":"R35-12-20241202","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1111\/j.1572-0241.2004.30444.x","article-title":"The prevalence of autoantibodies and autoimmune hepatitis in patients with nonalcoholic Fatty liver disease","volume":"99","author":"Adams","year":"2004","journal-title":"Am J Gastroenterol"},{"key":"R36-12-20241202","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/0016-5085(94)90078-7","article-title":"Patterns of nuclear immunofluorescence and reactivities to recombinant nuclear antigens in autoimmune hepatitis","volume":"107","author":"Czaja","year":"1994","journal-title":"Gastroenterology"},{"key":"R37-12-20241202","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/S0168-8278(96)80290-X","article-title":"Identification of cyclin A as a molecular target of antinuclear antibodies (ANA) in hepatic and non-hepatic autoimmune diseases","volume":"25","author":"Strassburg","year":"1996","journal-title":"J Hepatol"},{"key":"R38-12-20241202","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1002\/hep.510240515","article-title":"Frequency and significance of antibodies to actin in type 1 autoimmune hepatitis","volume":"24","author":"Czaja","year":"1996","journal-title":"Hepatology"},{"key":"R39-12-20241202","first-page":"331","article-title":"Microsomal antibodies in active chronic hepatitis and other disorders","volume":"15","author":"Rizzetto","year":"1973","journal-title":"Clin. Exp. Immunol"},{"key":"R40-12-20241202","doi-asserted-by":"crossref","first-page":"8256","DOI":"10.1073\/pnas.85.21.8256","article-title":"Antibodies against human cytochrome P-450db1 in autoimmune hepatitis type 2","volume":"85","author":"Zanger","year":"1988","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"R41-12-20241202","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1172\/JCI113949","article-title":"Major antigen of liver kidney microsomal antibodies in idiopathic autoimmune hepatitis is cytochrome P450db1","volume":"83","author":"Manns","year":"1989","journal-title":"J. Clin. Invest"},{"key":"R42-12-20241202","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1172\/JCI115443","article-title":"LKM-1 autoantibodies recognize a short linear sequence in P450IID6, a cytochrome P-450 monooxygenase","volume":"88","author":"Manns","year":"1991","journal-title":"J. Clin. Invest"},{"key":"R43-12-20241202","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1002\/eji.1830230519","article-title":"Identification and analysis of cytochrome P450IID6 antigenic sites recognized by anti-liver-kidney microsome type-1 antibodies (LKM1)","volume":"23","author":"Yamamoto","year":"1993","journal-title":"Eur. J. Immunol"},{"key":"R44-12-20241202","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1046\/j.1365-2249.1999.01027.x","article-title":"Overlapping but distinct specificities of anti-liver-kidney microsome antibodies in autoimmune hepatitis type II and hepatitis C revealed by recombinant native CYP2D6 and novel peptide epitopes","volume":"118","author":"Klein","year":"1999","journal-title":"Clin Exp Immunol"},{"key":"R45-12-20241202","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.4049\/jimmunol.170.3.1481","article-title":"Cytochrome P4502D6(193-212): A New Immunodominant Epitope and Target of Virus\/Self Cross-Reactivity in Liver Kidney Microsomal Autoantibody Type 1-Positive Liver Disease","volume":"170","author":"Kerkar","year":"2003","journal-title":"J Immunol"},{"key":"R46-12-20241202","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1080\/0891693021000069556","article-title":"A major CYP2D6 autoepitope in autoimmune hepatitis type 2 and chronic hepatitis C is a three-dimensional structure homologous to other cytochrome P450 autoantigens","volume":"35","author":"Sugimura","year":"2002","journal-title":"Autoimmunity"},{"key":"R47-12-20241202","doi-asserted-by":"crossref","first-page":"277","DOI":"10.4049\/jimmunol.169.1.277","article-title":"Key residues of a major cytochrome P4502D6 epitope are located on the surface of the molecule","volume":"169","author":"Ma","year":"2002","journal-title":"J Immunol"},{"key":"R48-12-20241202","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1002\/hep.20816","article-title":"LKM1 autoantibodies in chronic hepatitis C infection: a case of molecular mimicry?","volume":"42","author":"Marceau","year":"2005","journal-title":"Hepatology"},{"key":"R49-12-20241202","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1177\/039463200401700112","article-title":"Multiple viral\/self immunological cross-reactivity in liver kidney microsomal antibody positive hepatitis C virus infected patients is associated with the possession of HLA B51","volume":"17","author":"Bogdanos","year":"2004","journal-title":"Int J Immunopathol Pharmacol"},{"key":"R50-12-20241202","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1002\/hep.20109","article-title":"A murine model of type 2 autoimmune hepatitis: Xenoimmunization with human antigens","volume":"39","author":"Lapierre","year":"2004","journal-title":"Hepatology"},{"key":"R52-12-20241202","first-page":"3","article-title":"FDA Drug B","volume":"10","year":"1980","journal-title":"ull"},{"key":"R53-12-20241202","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1016\/S0016-5085(96)70020-3","article-title":"Autoantibodies against glucuronosyltransferases differ between viral hepatitis and autoimmune hepatitis","volume":"111","author":"Strassburg","year":"1996","journal-title":"Gastroenterology"},{"issue":"2","key":"R54-12-20241202","first-page":"A100","article-title":"Recognition of three different epitopes on UDP-glucuronosyltransferases by LKM-3 antibodies in patients with autoimmune hepatitis and hepatitis D","volume":"37","author":"Obermayer-Straub","year":"1995","journal-title":"Gut"},{"key":"R55-12-20241202","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/S0140-6736(94)91966-6","article-title":"Recognition of uridine diphosphate glucuronosyl transferases by LKM-3 antibodies in chronic hepatitis D","volume":"344","author":"Philipp","year":"1994","journal-title":"Lancet"},{"key":"R56-12-20241202","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1111\/j.1572-0241.2001.03383.x","article-title":"LKM3 autoantibodies in hepatitis C cirrhosis: a further phenomenon of the HCV-induced autoimmunity","volume":"96","author":"Csepregi","year":"2001","journal-title":"Am J Gastroenterol"},{"key":"R57-12-20241202","doi-asserted-by":"crossref","first-page":"9739","DOI":"10.1073\/pnas.89.20.9739","article-title":"Autoantibodies against a serine tRNA-protein complex implicated in cotranslational selenocysteine insertion","volume":"89","author":"Gelpi C","year":"1992","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R58-12-20241202","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/S0140-6736(87)92024-1","article-title":"Characterisation of a new subgroup of autoimmune chronic active hepatitis by autoantibodies against a soluble liver antigen","volume":"1","author":"Manns","year":"1987","journal-title":"Lancet"},{"key":"R59-12-20241202","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1053\/jhep.2001.22218","article-title":"Soluble liver antigen: isolation of a 35-kd recombinant protein (SLA-p35) specifically recognizing sera from patients with autoimmune hepatitis","volume":"33","author":"Volkmann","year":"2001","journal-title":"Hepatology"},{"key":"R60-12-20241202","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1016\/S0140-6736(00)02166-8","article-title":"Identification of target antigen for SLA\/LP autoantibodies in autoimmune hepatitis [see comments]","volume":"355","author":"Wies","year":"2000","journal-title":"Lancet"},{"key":"R61-12-20241202","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1111\/j.1572-0241.2002.05479.x","article-title":"Antibodies to soluble liver antigen\/liver pancreas and HLA risk factors for type 1 autoimmune hepatitis","volume":"97","author":"Czaja","year":"2002","journal-title":"Am J Gastroenterol"},{"key":"R62-12-20241202","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1080\/08916930410001686260","article-title":"Anti-soluble liver antigen (SLA) antibodies in chronic HCV infection","volume":"37","author":"Vitozzi","year":"2004","journal-title":"Autoimmunity"},{"key":"R63-12-20241202","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1053\/jhep.2002.32092","article-title":"Antibodies to conformational epitopes of soluble liver antigen define a severe form of autoimmune liver disease","volume":"35","author":"Ma","year":"2002","journal-title":"Hepatology"},{"key":"R64-12-20241202","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1046\/j.1365-2249.2000.01280.x","article-title":"Isolation and characterization of cDNA encoding the antigenic protein of the human tRNP(S-er) Sec complex recognized by autoantibodies from patients withtype-1 autoimmune hepatitis","volume":"121","author":"Costa","year":"2000","journal-title":"Clin Exp Immunol"},{"key":"R65-12-20241202","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1053\/jhep.2002.30699","article-title":"Fine specificity of autoantibodies to soluble liver antigen and liver\/pancreas","volume":"35","author":"Herkel","year":"2002","journal-title":"Hepatology"},{"key":"R66-12-20241202","first-page":"58","article-title":"Anti-liver cytosolic antigen type 1 (LC1) antibodies in childhood autoimmune liver disease","volume":"21","author":"Han","year":"1995","journal-title":"Hepatology"},{"key":"R67-12-20241202","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1136\/gut.36.5.749","article-title":"Liver cytosolic 1 antigen-antibody system in type 2 autoimmune hepatitis and hepatitis C virus infection","volume":"36","author":"Lenzi","year":"1995","journal-title":"Gut"},{"key":"R68-12-20241202","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1002\/hep.1840080632","article-title":"Antibody to liver cytosol (anti-LC1) in patients with autoimmune chronic active hepatitis type 2","volume":"8","author":"Martini","year":"1988","journal-title":"Hepatology"},{"key":"R69-12-20241202","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/S0016-5085(99)70186-1","article-title":"Fomiminotransferase cyclodeaminase is an organ specific autoantigen recognized by sera of patients with autoimmune hepatitis","volume":"116","author":"Lapierre","year":"1999","journal-title":"Gastroenterology"},{"key":"R70-12-20241202","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0969-2126(00)00078-2","article-title":"The crystal structure of the formiminotransferase domain of formiminotransferasecyclodeaminase: implications for substrate channeling in a bifunctional enzyme","volume":"8","author":"Kohls","year":"2000","journal-title":"Structure Fold Des"},{"key":"R71-12-20241202","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1002\/eji.200323857","article-title":"Characterization of the B cell response of patients with anti-liver cytosol autoantibodies in type 2 autoimmune hepatitis","volume":"33","author":"Lapierre","year":"2003","journal-title":"Eur J Immunol"},{"key":"R72-12-20241202","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.jaut.2003.11.001","article-title":"Anti-LC1 autoantibodies in patients with chronic hepatitis C virus infection","volume":"22","author":"Beland","year":"2004","journal-title":"J Autoimmun"},{"key":"R73-12-20241202","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1136\/gut.42.5.721","article-title":"Liver\/kidney microsomal antibody type 1 and liver cytosol antibody type 1 concentrations in type 2 autoimmune hepatitis","volume":"42","author":"Muratori","year":"1998","journal-title":"Gut"},{"key":"R74-12-20241202","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0168-8278(05)80176-X","article-title":"Autoantibodies against the human asialoglycoprotein receptor: Effects of therapy in autoimmune and virus-induced chronic active hepatitis","volume":"19","author":"Treichel","year":"1993","journal-title":"J. Hepatology"},{"key":"R75-12-20241202","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1016\/S0140-6736(84)91167-X","article-title":"Antibodies to liver-specific protein predict outcome of treatment withdrawal in autoimmune chronic active hepatitis","volume":"2","author":"McFarlane","year":"1984","journal-title":"Lancet"},{"key":"R76-12-20241202","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1002\/hep.1840110413","article-title":"Autoantibodies to human asialoglycoprotein receptor in autoimmune-type chronic hepatitis","volume":"11","author":"Treichel","year":"1990","journal-title":"Hepatology"},{"key":"R77-12-20241202","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1007\/BF02088738","article-title":"Frequency and significance of antibodies to asialoglycoprotein receptor in type 1 autoimmune hepatitis","volume":"41","author":"Czaja","year":"1996","journal-title":"Dig. Dis. Sci"},{"key":"R78-12-20241202","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1016\/0016-5085(92)91518-9","article-title":"Frequency and significance of antibodies to liver\/kidney microsome type 1 in adults with chronic active hepatitis","volume":"103","author":"Czaja","year":"1992","journal-title":"Gastroenterology"},{"key":"R79-12-20241202","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/S0168-8278(99)80096-8","article-title":"Behavior and significance of autoantibodies in type 1 autoimmune hepatitis","volume":"30","author":"Czaja","year":"1999","journal-title":"J Hepatol"},{"key":"R80-12-20241202","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/S0168-8278(99)80342-0","article-title":"Clinical significance of autoantibodies to soluble liver antigen in autoimmune hepatitis","volume":"31","author":"Kanzler","year":"1999","journal-title":"J Hepatol"},{"key":"R81-12-20241202","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1080\/08916930410001702469","article-title":"Nonstandard antibodies as prognostic markers in autoimmune hepatitis","volume":"37","author":"Czaja","year":"2004","journal-title":"Autoimmunity"},{"key":"R82-12-20241202","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1136\/gut.51.2.259","article-title":"Establishment of standardised SLA\/LP immunoassays: specificity for autoimmune hepatitis, worldwide occurrence, and clinical characteristics","volume":"51","author":"Baeres","year":"2002","journal-title":"Gut"},{"key":"R83-12-20241202","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/85228","article-title":"Autoimmunity through infection or immunization?","volume":"2","author":"Regner","year":"2001","journal-title":"Nat Immunol"},{"key":"R84-12-20241202","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1038\/ni0901-759","article-title":"Autoimmune diseases: genes, bugs and failed regulation","volume":"2","author":"Ermann","year":"2001","journal-title":"Nat Immunol"},{"key":"R85-12-20241202","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.jhep.2004.06.001","article-title":"Genetics of autoimmune and viral liver diseases; understanding the issues","volume":"41","author":"Donaldson","year":"2004","journal-title":"J Hepatol"},{"key":"R86-12-20241202","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1136\/gut.2003.031732","article-title":"Genetics of liver disease: immunogenetics and disease pathogenesis","volume":"53","author":"Donaldson","year":"2004","journal-title":"Gut"},{"key":"R87-12-20241202","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1056\/NEJM200009073431006","article-title":"The HLA system. First of two parts","volume":"343","author":"Klein","year":"2000","journal-title":"N Engl J Med"},{"key":"R88-12-20241202","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1056\/NEJM200009143431106","article-title":"The HLA system. Second of two parts","volume":"343","author":"Klein","year":"2000","journal-title":"N Engl J Med"},{"key":"R89-12-20241202","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1053\/gast.1997.v112.pm9178696","article-title":"Allelic basis for HLA-encoded susceptibility to type 1 autoimmune hepatitis","volume":"112","author":"Strettel","year":"1997","journal-title":"Gastroenterology"},{"key":"R90-12-20241202","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1002\/hep.510250211","article-title":"Associations between alleles of the major histocompatibility complex and type 1 autoimmune hepatitis","volume":"25","author":"Czaja","year":"1997","journal-title":"Hepatology"},{"key":"R91-12-20241202","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1016\/0016-5085(93)90157-8","article-title":"Significance of HLA DR4 in type 1 autoimmune hepatitis","volume":"105","author":"Czaja","year":"1993","journal-title":"Gastroenterology"},{"key":"R92-12-20241202","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1002\/hep.1840200133","article-title":"The molecular genetics of autoimmune liver disease","volume":"20","author":"Donaldson","year":"1994","journal-title":"Hepatology"},{"key":"R93-12-20241202","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1016\/0016-5085(93)90359-K","article-title":"Early-onset autoimmune hepatitis is associated with a C4A gene deletion","volume":"104","author":"Scully","year":"1993","journal-title":"Gastroenterology"},{"key":"R94-12-20241202","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/S0016-5085(99)70458-0","article-title":"Cytokine polymorphisms associated with clinical features and treatment outcome in type 1 autoimmune hepatitis","volume":"117","author":"Czaja","year":"1999","journal-title":"Gastroenterology"},{"key":"R95-12-20241202","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1002\/hep.510300412","article-title":"Frequency and nature of cytokine gene polymorphisms in type 1 autoimmune hepatitis","volume":"30","author":"Cookson","year":"1999","journal-title":"Hepatology"},{"key":"R96-12-20241202","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/S0168-8278(01)00072-1","article-title":"Autoimmune hepatitis in Brazilian patients is not linked to tumor necrosis factor alpha polymorphisms at position -308","volume":"35","author":"Bittencourt","year":"2001","journal-title":"J Hepatol"},{"key":"R97-12-20241202","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1002\/hep.510310110","article-title":"Cytotoxic T lymphocyteantigen-4 (CTLA-4) gene polymorphisms and susceptibility to type 1 autoimmune hepatitis","volume":"31","author":"Agarwal","year":"2000","journal-title":"Hepatology"},{"key":"R98-12-20241202","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1038\/nature01621","article-title":"Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease","volume":"423","author":"Ueda","year":"2003","journal-title":"Nature"},{"key":"R99-12-20241202","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1016\/S0198-8859(01)00344-5","article-title":"CTLA-4\/CD 28 region polymorphisms in children from families with autoimmune hepatitis","volume":"62","author":"Djilali-Saiah","year":"2001","journal-title":"Hum Immunol"},{"key":"R100-12-20241202","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1111\/j.1572-0241.2003.07525.x","article-title":"Cytotoxic T lymphocyte antigen-4 gene polymorphisms do not confer susceptibility to autoimmune hepatitis types 1 and 2 in Brazil","volume":"98","author":"Bittencourt","year":"2003","journal-title":"Am J Gastroenterol"},{"key":"R101-12-20241202","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1111\/j.1572-0241.2005.41053.x","article-title":"Fas polymorphisms influence susceptibility to autoimmune hepatitis","volume":"100","author":"Hiraide","year":"2005","journal-title":"Am J Gastroenterol"},{"key":"R102-12-20241202","doi-asserted-by":"crossref","first-page":"2768","DOI":"10.3748\/wjg.v11.i18.2768","article-title":"Genetic association of cytokines polymorphisms with autoimmune hepatitis and primary biliary cirrhosis in the Chinese","volume":"11","author":"Fan","year":"2005","journal-title":"World J Gastroenterol"},{"key":"R103-12-20241202","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1111\/j.1440-1746.2005.03532.x","article-title":"Genetic association of vitamin D receptor polymorphisms with autoimmune hepatitis and primary biliary cirrhosis in the Chinese","volume":"20","author":"Fan","year":"2005","journal-title":"J Gastroenterol Hepatol"},{"key":"R104-12-20241202","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1053\/jhep.2002.30084","article-title":"Genetic association of vitamin D receptor polymorphisms with primary biliary cirrhosis and autoimmune hepatitis","volume":"35","author":"Vogel","year":"2002","journal-title":"Hepatology"},{"key":"R105-12-20241202","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/sj.gene.6363918","article-title":"77 C\/G mutation in the tyrosine phosphatase CD45 gene and autoimmune hepatitis: evidence for a genetic link","volume":"4","author":"Vogel","year":"2003","journal-title":"Genes Immun"},{"key":"R107-12-20241202","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1056\/NEJM199006283222601","article-title":"Clinical variation of autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) in a series of 68 patients","volume":"322","author":"Ahonen","year":"1990","journal-title":"N Engl J Med"},{"key":"R108-12-20241202","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1038\/ng1297-393","article-title":"Positional cloning of the APECED gene","volume":"17","author":"Nagamine","year":"1997","journal-title":"Nat Genet"},{"key":"R109-12-20241202","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s00109-001-0306-2","article-title":"The genetic background of autoimmune polyendocrinopathy-candidiasis-Ectodermal dystrophy and its autoimmune disease components","volume":"80","author":"Vogel","year":"2002","journal-title":"J Mol Med"},{"key":"R111-12-20241202","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1053\/jhep.2001.24031","article-title":"Autoimmune regulator AIRE: Evidence for genetic differences between autoimmune hepatitis and hepatitis as part of the autoimmune polyglandular syndrome type 1","volume":"33","author":"Vogel","year":"2001","journal-title":"Hepatology"},{"key":"R112-12-20241202","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/j.jhep.2004.02.023","article-title":"Linkage disequilibrium between HLA class II region and autoimmune hepatitis in pediatric patients","volume":"40","author":"Djilali-Saiah","year":"2004","journal-title":"J Hepatol"},{"key":"R113-12-20241202","first-page":"1353","article-title":"Cytochrome P450 1A2 is a hepatic autoantigen in autoimmune polyglandular syndrome type 1","volume":"82","author":"Clemente","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"R114-12-20241202","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/S0016-5085(98)70484-6","article-title":"Two cytochromes P450 are major hepatocellular autoantigens in autoimmune polyglandular syndrome type 1","volume":"114","author":"Clemente","year":"1998","journal-title":"Gastroenterology"},{"key":"R115-12-20241202","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1053\/gast.2001.27103","article-title":"Hepatic autoantigens in patients with autoimmune polyendocrinopathycandidiasis-ectodermal dystrophy","volume":"121","author":"Obermayer-Straub","year":"2001","journal-title":"Gastroenterology"},{"key":"R116-12-20241202","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1210\/jc.2003-030279","article-title":"Prevalence and clinical associations of 10 defined autoantibodies in autoimmune polyendocrine syndrome type I","volume":"89","author":"Soderbergh","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"R117-12-20241202","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/0016-5085(88)90503-3","article-title":"Features reflective of early prognosis in corticosteroid-treated severe autoimmune chronic active hepatitis","volume":"95","author":"Czaja","year":"1988","journal-title":"Gastroenterology"},{"key":"R118-12-20241202","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1002\/hep.1840060302","article-title":"The prognosis of chronic active hepatitis without cirrhosis in relation to bridging necrosis","volume":"6","author":"Cooksley","year":"1986","journal-title":"Hepatology"},{"key":"R119-12-20241202","doi-asserted-by":"crossref","first-page":"49","DOI":"10.2165\/00003495-199957010-00005","article-title":"Drug therapy in the management of type 1 autoimmune hepatitis","volume":"57","author":"Czaja","year":"1999","journal-title":"Drugs"},{"key":"R121-12-20241202","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1002\/hep.1840150208","article-title":"Prognostic features and role of liver transplantation in severe corticoid-treated autoimmune chronic active hepatitis","volume":"15","author":"Sanchez-Urdazpal","year":"1991","journal-title":"Hepatology"},{"key":"R122-12-20241202","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/0016-5085(83)90030-6","article-title":"Autoimmune features as determinants of prognosis in steroid-treated chronic active hepatitis of uncertain etiology","volume":"85","author":"Czaja","year":"1983","journal-title":"Gastroenterology"},{"key":"R123-12-20241202","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1053\/jhep.2002.34944","article-title":"Diagnosis and treatment of autoimmune hepatitis","volume":"36","author":"Czaja","year":"2002","journal-title":"Hepatology"},{"key":"R124-12-20241202","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1055\/s-2002-35706","article-title":"Treatment of autoimmune hepatitis","volume":"22","author":"Czaja","year":"2002","journal-title":"Semin Liver Dis"},{"key":"R125-12-20241202","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1053\/gast.2001.24227","article-title":"Autoimmune hepatitis: clinical challenges","volume":"120","author":"Manns","year":"2001","journal-title":"Gastroenterology"},{"key":"R126-12-20241202","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1136\/gut.16.11.876","article-title":"Prednisone for chronic active liver disease: dose titration, standard dose and combination with azathioprine compound","volume":"16","author":"Summerskill","year":"1975","journal-title":"Gut"},{"key":"R127-12-20241202","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1053\/jhep.2002.30991","article-title":"Current and novel immunosuppressive therapy for autoimmune hepatitis","volume":"35","author":"Heneghan","year":"2002","journal-title":"Hepatology"},{"key":"R128-12-20241202","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1111\/j.1365-2036.1994.tb00334.x","article-title":"Oral budesonide for treatment of autoimmune chronic hepatitis","volume":"8","author":"Danielson","year":"1994","journal-title":"Aliment. Pharmacol. Ther"},{"key":"R129-12-20241202","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1053\/gast.2000.0010000001","article-title":"Failure of budesonide in a pilot study of treatmentdependent autoimmune hepatitis","volume":"119","author":"Czaja","year":"2000","journal-title":"Gastroenterology"},{"key":"R130-12-20241202","first-page":"630","article-title":"Deflazacort for longterm maintenance of remission in type I autoimmune hepatitis","volume":"91","author":"Rebollo Bernardez","year":"1999","journal-title":"Rev Esp Enferm Dig"},{"key":"R131-12-20241202","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/S0168-8278(99)80065-8","article-title":"Short-term cyclosporine induces a remission of autoimmune hepatitis in children","volume":"30","author":"Alvarez","year":"1999","journal-title":"J. Hepatol"},{"key":"R132-12-20241202","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/S0168-8278(00)80271-8","article-title":"Mycophenolate mofetil for maintenance of remission in autoimmune hepatitis in patients resistant to or intolerant of azathioprine","volume":"33","author":"Richardson","year":"2000","journal-title":"J Hepatol"},{"key":"R133-12-20241202","first-page":"571","article-title":"Cyclophosphamide as alternative immunosuppressive therapy for autoimmune hepatitis - report of three cases","volume":"35","author":"Kanzler","year":"1996","journal-title":"Z. Gastroenterol"},{"key":"R134-12-20241202","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/hep.1840110104","article-title":"Hepatic expression of class I and class II major histocompatibility complex molecules in primary biliary cirrhosis: effect of ursodeoxycholic acid","volume":"11","author":"Calmus","year":"1990","journal-title":"Hepatology"},{"key":"R135-12-20241202","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1111\/j.1440-1746.1998.tb00674.x","article-title":"Efficacy of ursodeoxycholic acid in Japanese patients with type 1 autoimmune hepatitis [see comments]","volume":"13","author":"Nakamura","year":"1998","journal-title":"J Gastroenterol Hepatol"},{"key":"R136-12-20241202","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1002\/hep.510300603","article-title":"Ursodeoxycholic acid as adjunctive therapy for problematic type 1 autoimmune hepatitis: a randomized placebo-controlled treatment trial","volume":"30","author":"Czaja","year":"1999","journal-title":"Hepatology"},{"key":"R137-12-20241202","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1016\/S0002-9270(00)01059-5","article-title":"Budesonide or prednisone in combination with ursodeoxycholic acid in primary sclerosing cholangitis: a randomized double-blind pilot study. Belgian-Dutch PSC Study Group [see comments]","volume":"95","author":"van Hoogstraten","year":"2000","journal-title":"Am J Gastroenterol"},{"key":"R138-12-20241202","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1111\/j.1478-3231.2005.01122.x","article-title":"Budesonide in previously untreated autoimmune hepatitis","volume":"25","author":"Wiegand","year":"2005","journal-title":"Liver Int"},{"key":"R140-12-20241202","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1111\/j.1478-3231.2005.01121.x","article-title":"Early treatment response predicts the need for liver transplantation in autoimmune hepatitis","volume":"25","author":"Tan","year":"2005","journal-title":"Liver Int"},{"key":"R141-12-20241202","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/j.1399-0012.2004.00117.x","article-title":"Long-term outcome of liver transplantation for autoimmune hepatitis","volume":"18","author":"Vogel","year":"2004","journal-title":"Clin Transplant"},{"key":"R142-12-20241202","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1136\/gut.52.6.893","article-title":"A 10 year follow up study of patients transplanted for autoimmune hepatitis: histological recurrence precedes clinical and biochemical recurrence","volume":"52","author":"Duclos-Vallee","year":"2003","journal-title":"Gut"},{"key":"R143-12-20241202","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1053\/jhep.2000.16666","article-title":"Liver transplantation for autoimmune hepatitis","volume":"32","author":"Reich","year":"2000","journal-title":"Hepatology"},{"key":"R144-12-20241202","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1097\/00007890-199201000-00027","article-title":"Disease recurrence and rejection following liver transplantation for autoimmune chronic active liver disease","volume":"53","author":"Wright","year":"1992","journal-title":"Transplantation"},{"key":"R145-12-20241202","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1097\/00007890-199812270-00013","article-title":"Outcome of autoimmune hepatitis after liver transplantation","volume":"66","author":"Prados","year":"1998","journal-title":"Transplantation"},{"key":"R146-12-20241202","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1053\/jlts.2001.21449","article-title":"Recurrent autoimmune hepatitis after orthotopic liver transplantation","volume":"7","author":"Gonzalez-Koch","year":"2001","journal-title":"Liver Transpl"},{"key":"R147-12-20241202","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/S0041-1345(98)01692-3","article-title":"Recurrence of autoimmune hepatitis after liver transplantation","volume":"31","author":"G\u00f6tz","year":"1999","journal-title":"Transplant. Proc"},{"key":"R148-12-20241202","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1097\/00007890-199907270-00016","article-title":"Recurrence of autoimmune hepatitis after liver transplantation","volume":"68","author":"Milkiewicz","year":"1999","journal-title":"Transplantation"},{"key":"R149-12-20241202","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0168-8278(99)80017-8","article-title":"Longterm follow-up after liver transplantation for autoimmune hepatitis: evidence of recurrence of primary disease","volume":"30","author":"Ratziu","year":"1999","journal-title":"J Hepatol"},{"key":"R150-12-20241202","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0168-8278(96)80001-8","article-title":"Recurrence of primary biliary cirrhosis in the liver allograft: the effect of immunosuppression","volume":"24","author":"Dmitrewski","year":"1996","journal-title":"J Hepatol"},{"key":"R151-12-20241202","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1097\/00007890-200107270-00018","article-title":"Posttransplant immune hepatitis in pediatric liver transplant recipients: incidence and maintenance therapy with azathioprine","volume":"72","author":"Andries","year":"2001","journal-title":"Transplantation"},{"key":"R152-12-20241202","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1053\/jhep.2002.31167","article-title":"Response to steroids in de novo autoimmune hepatitis after liver transplantation","volume":"35","author":"Salcedo","year":"2002","journal-title":"Hepatology"},{"key":"R153-12-20241202","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1111\/j.1600-6143.2005.00801.x","article-title":"Rapamycin successfully treats post-transplant autoimmune hepatitis","volume":"5","author":"Kerkar","year":"2005","journal-title":"Am J Transplant"},{"key":"R154-12-20241202","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S0140-6736(97)06478-7","article-title":"De-novo autoimmune hepatitis after liver transplantation","volume":"351","author":"Kerkar","year":"1998","journal-title":"Lancet"},{"key":"R155-12-20241202","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1097\/01.TP.0000132328.33460.43","article-title":"Outcome and risk factors of de novo autoimmune hepatitis in living-donor liver transplantation","volume":"78","author":"Miyagawa-Hayashino","year":"2004","journal-title":"Transplantation"},{"key":"R156-12-20241202","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1053\/jhep.2001.26756","article-title":"Graft dysfunction mimicking autoimmune hepatitis following liver transplantation in adults","volume":"34","author":"Heneghan","year":"2001","journal-title":"Hepatology"},{"key":"R157-12-20241202","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.jhep.2003.10.022","article-title":"De novo autoimmune hepatitis after liver transplantation","volume":"40","author":"Mieli-Vergani","year":"2004","journal-title":"J Hepatol"},{"key":"R158-12-20241202","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1002\/lt.20209","article-title":"Glutathione S-transferase T1 mismatch constitutes a risk factor for de novo immune hepatitis after liver transplantation","volume":"10","author":"Aguilera","year":"2004","journal-title":"Liver Transpl"},{"key":"RU159-12-20241202","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1177\/021849230401200205","article-title":"Human leukocyte antigens in hypertrophic cardiomyopathy patients in South India","volume":"12","author":"Shankarkumar","year":"2004","journal-title":"Asian Cardiovasc Thorac Ann"},{"key":"RU160-12-20241202","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/S0168-8278(98)80347-4","article-title":"MHC class II sequences of susceptibility and protection in Mexicans with autoimmune hepatitis","volume":"28","author":"Vazquez-Garcia","year":"1998","journal-title":"J. Hepatol"},{"key":"RU161-12-20241202","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.jhep.2004.12.019","article-title":"Genetic analysis of the HLA region of Japanese patients with type 1 autoimmune hepatitis","volume":"42","author":"Yoshizawa","year":"2005","journal-title":"J Hepatol"}],"container-title":["Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fhep.21059","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.lww.com\/01515467-200602001-00012","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,2]],"date-time":"2024-12-02T17:02:16Z","timestamp":1733158936000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01515467-200602001-00012"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,2]]},"references-count":156,"journal-issue":{"issue":"Supplement 1","published-print":{"date-parts":[[2006]]}},"URL":"https:\/\/doi.org\/10.1002\/hep.21059","relation":{},"ISSN":["0270-9139"],"issn-type":[{"value":"0270-9139","type":"print"}],"subject":[],"published":{"date-parts":[[2006,2]]}}}